Celsite T202F B. Braun Catheter with Synchromed II Medtronic Pump for Hepatic Artery Infusion Therapy Is a Safe Alternative to Codman Pump Discontinuation: The First Latin-American HAIP Program Early Experience

ABSTRACT

Introduction: The Codman 3000 pump was the commonest system used in the U.S. for HAIP until 2018 device discontinuation. There are many countries abroad where Codman devices have never been available. The aim is to describe our early experience with the use of Celsite T202F B. Braun catheter-Syncromed II Medtronic pump in the first Latin American HAIP program. Method(s) We describe early outcomes of 6 patients with HAIP that used Celsite T202F, 6.5 Fr B. Braun catheter-Synchromed II Medtronic pump combination. Result(s) 2 patients were female (33.3%). Unresectable colorectal liver metastasis (CRLM) in 3 patients (50%), adjuvant chemotherapy for CRLM in 1 (16.6%) and intrahepatic cholangiocarcinoma in 2 (33.3%). No extra hepatic perfusion was documented. Complications were present in 4 patients (66.6%). 3 (50%) were not related to the hepatic pump 1 COVID-19 pneumonia, 1 colonic anastomosis leakage and 1 intraabdominal collection. One patient (16.6%) presented a pump pocket seroma. Floxuridine was the intra arterial drug administered in all patients. The median number of cycles administered was 6. All patients have partial response to date. The median follow up was 234 days. No catheter disconnection or dysfunction events occurred. Conclusion(s) The use of the Celsite B Braun catheter-Medtronic pump is a feasible and safe option for HAIP. A HAIP program can be implemented safely in Latin-America. [Formula presented] Figure 1. Celsite T202F B. Braun catheter connection with Synchromed II Medtronic pump. Copyright © 2022